title: Sexuality and fertility in women with Addison's disease.
abstract: BACKGROUND
  Females with primary adrenal insufficiency (Addison's disease) have reduced levels of circulating androgens, which are allegedly important for sexual functioning.
  
  
  OBJECTIVE
  The aim was to determine peripheral androgen status, sexual functioning, and birth rates in Addison's disease females.
  
  
  METHODS
  In a postal survey, all 269 females in the Norwegian Addison's registry were invited to complete the Sexual Activity Questionnaire (SAQ) and registration of childbirths. Blood samples were analyzed for 5alpha-androstane-3alpha,17beta-diol-3-glucuronide (3alpha-Diol-G) and compared with blood donor levels. The SAQ scores were compared with 740 age-matched controls from the general population and 234 women subjected to risk-reducing salpingo-oophorectomy. Fertility was estimated as standardized incidence ratio for birth; the expected number of births was estimated from population statistics.
  
  
  RESULTS
  The SAQ was completed by 174 (65%) of the Addison's patients. Those not taking DHEA had significantly lower 3alpha-Diol-G levels than blood donors (mean, 0.53 vs. 2.2 ng/ml; P < 0.0001), whereas those on DHEA treatment had elevated levels (mean, 5.8 vs. 2.2 ng/ml; P = 0.002). The Addison's disease females were equally sexually active as the controls, but they reported significantly higher pleasure and less discomfort. They reported lower pleasure but less discomfort than the risk-reducing salpingo-oophorectomy women. The fertility was significantly reduced in females with Addison's disease; 54 children were born to mothers with established diagnosis (87.5 expected), yielding a standardized incidence ratio for birth of 0.69 (confidence interval, 0.52-0.86).
  
  
  CONCLUSIONS
  Despite androgen depletion, females with Addison's disease do not report impaired sexuality. The fertility is reduced after the diagnosis is made; the reasons for this remain unknown.
authors.affiliation: Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway. mmer@helse-bergen.no
authors.forename: Martina M
authors.initials: MM
authors.lastname: Erichsen
authors.forename: Eystein S
authors.initials: ES
authors.lastname: Husebye
authors.forename: Trond M
authors.initials: TM
authors.lastname: Michelsen
authors.forename: Alv A
authors.initials: AA
authors.lastname: Dahl
authors.forename: Kristian
authors.initials: K
authors.lastname: Løvås
mesh_terms: D000224:Addison Disease / Q000097:blood / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000728:Androgens / Q000097:blood; D016022:Case-Control Studies; D005260:Female; D005298:Fertility / Q000502:physiology*; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D018873:Pregnancy Rate; D016649:Primary Ovarian Insufficiency / Q000097:blood / Q000150:complications / Q000453:epidemiology; D012735:Sexual Dysfunction, Physiological / Q000097:blood / Q000150:complications / Q000453:epidemiology; D019529:Sexuality / Q000502:physiology*; D055815:Young Adult
chemical_list: D000728:Androgens